Sackler-Owned Mundipharma Taps Deutsche Bank for Sale

Mundipharma International Ltd., a global pharmaceutical company owned by the billionaire Sackler family, is working with Deutsche Bank AG as it weighs a sale of the business amid interest from potential buyers, people familiar with the matter said, Bloomberg News reported. A sale of the Cambridge, U.K.-based business could fetch from $3 billion to $5 billion, the people said, asking not to be identified because the matter is private. The company has attracted initial interest from other pharmaceutical companies as well private equity firms, the people said. While the company prefers to sell the entire business to a single buyer, it’s open to potential piecemeal deals depending on the offers, one of the people said. A formal process could kick off as soon as in the middle of this year, they said. Read more